Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches
- PMID: 18552976
- PMCID: PMC2424319
- DOI: 10.2119/2008-00053.Begemann
Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches
Abstract
Molecular mechanisms underlying bipolar affective disorders are unknown. Difficulties arise from genetic and phenotypic heterogeneity of patients and the lack of animal models. Thus, we focused on only one patient (n = 1) with an extreme form of rapid cycling. Ribonucleic acid (RNA) from peripheral blood mononuclear cells (PBMC) was analyzed in a three-tiered approach under widely standardized conditions. Firstly, RNA was extracted from PBMC of eight blood samples, obtained on two consecutive days within one particular episode, including two different consecutive depressive and two different consecutive manic episodes, and submitted to (1) screening by microarray hybridizations, followed by (2) detailed bioinformatic analysis, and (3) confirmation of episode-specific regulation of genes by quantitative real-time polymerase chain reaction (qRT-PCR).Secondly, results were validated in additional blood samples obtained one to two years later. Among gene transcripts elevated in depressed episodes were prostaglandin D synthetase (PTGDS) and prostaglandin D2 11-ketoreductase (AKR1C3), both involved in hibernation. We hypothesized them to account for some of the rapid cycling symptoms. A subsequent treatment approach over 5 months applying the cyclooxygenase inhibitor celecoxib (2 x 200 mg daily) resulted in reduced severity rating of both depressed and manic episodes. This case suggests that rapid cycling is a systemic disease, resembling hibernation, with prostaglandins playing a mediator role.
Figures


Similar articles
-
Reduced mRNA expression of PTGDS in peripheral blood mononuclear cells of rapid-cycling bipolar disorder patients compared with healthy control subjects.Int J Neuropsychopharmacol. 2014 Dec 7;18(5):pyu101. doi: 10.1093/ijnp/pyu101. Int J Neuropsychopharmacol. 2014. PMID: 25522430 Free PMC article.
-
A role for prostaglandins in rapid cycling suggested by episode-specific gene expression shifts in peripheral blood mononuclear cells: a preliminary report.Bipolar Disord. 2014 Dec;16(8):881-8. doi: 10.1111/bdi.12223. Epub 2014 Jun 25. Bipolar Disord. 2014. PMID: 24964373
-
Clinical implications of aldo-keto reductase family 1 member C3 and its relationship with lipocalin 2 in cancer of the uterine cervix.Gynecol Oncol. 2014 Feb;132(2):474-82. doi: 10.1016/j.ygyno.2013.11.032. Epub 2013 Dec 4. Gynecol Oncol. 2014. PMID: 24316309
-
Depot-specific prostaglandin synthesis in human adipose tissue: a novel possible mechanism of adipogenesis.Gene. 2006 Oct 1;380(2):137-43. doi: 10.1016/j.gene.2006.05.026. Epub 2006 Jun 10. Gene. 2006. PMID: 16842938
-
[Antipsychotics in bipolar disorders].Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5. Encephale. 2004. PMID: 15627046 Review. French.
Cited by
-
Convergent functional genomic studies of ω-3 fatty acids in stress reactivity, bipolar disorder and alcoholism.Transl Psychiatry. 2011 Apr 26;1(4):e4. doi: 10.1038/tp.2011.1. Transl Psychiatry. 2011. PMID: 22832392 Free PMC article.
-
Monitoring candidate gene expression variations before, during and after a first major depressive episode in a 51-year-old man.BMC Psychiatry. 2014 Mar 12;14:73. doi: 10.1186/1471-244X-14-73. BMC Psychiatry. 2014. PMID: 24620999 Free PMC article.
-
Reduced mRNA expression of PTGDS in peripheral blood mononuclear cells of rapid-cycling bipolar disorder patients compared with healthy control subjects.Int J Neuropsychopharmacol. 2014 Dec 7;18(5):pyu101. doi: 10.1093/ijnp/pyu101. Int J Neuropsychopharmacol. 2014. PMID: 25522430 Free PMC article.
-
Inflammatory biomarkers and depression.Neurotox Res. 2011 Feb;19(2):308-18. doi: 10.1007/s12640-010-9210-2. Epub 2010 Jul 24. Neurotox Res. 2011. PMID: 20658274 Review.
-
A new paradigm for the prediction of antidepressant treatment response.Dialogues Clin Neurosci. 2009;11(4):435-46. doi: 10.31887/DCNS.2009.11.4/afleuchter. Dialogues Clin Neurosci. 2009. PMID: 20135901 Free PMC article.
References
-
- Dunner DL, Fieve RR. Clinical factors in lithium-carbonate prophylaxis failure. Archives of General Psychiatry. 1974;30:229–233. - PubMed
-
- Muller-Oerlinghausen B, Berghofer A, Bauer M. Bipolar disorder. Lancet. 2002;359:241–247. - PubMed
-
- Coryell W. Rapid cycling bipolar disorder: clinical characteristics and treatment options. CNS Drugs. 2005;19:557–569. - PubMed
-
- Papadimitriou GN, Calabrese JR, Dikeos DG, Christodoulou GN. Rapid cycling bipolar disorder: biology and pathogenesis. Int J Neuropsychopharmacol. 2005;8:281–292. - PubMed
-
- Schneck CD, Miklowitz DJ, Calabrese JR, et al. Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program. Am J Psychiatry. 2004;161:1902–1908. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous